Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer

Gynecologic Oncology

Volumn 123, Issue 2, 2011, Pages 214-220

  Koskas, Martin ^a,b   Bendifallah, Sofiane ^c   Luton, Dominique ^a,b   Darai, Emile ^c,d   Rouzier, Roman ^c,d  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL TENON   (France)

^d CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

Endometrial cancer; Nomogram; Prediction; Radiotherapy; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CALIBRATION; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NOMOGRAM; OVERALL SURVIVAL; POPULATION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; SEER PROGRAM;

EID: 80054740912     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.08.006     Document Type: Article

References (20)

1. T.J. Smith, L.A. Dow, E. Virago, J. Khatcheressian, L.J. Lyckholm, and R. Matsuyama Giving honest information to patients with advanced cancer maintains hope Oncology 24 2010 521 525
2. N. Bansal, T.J. Herzog, V.E. Seshan, P.B. Schiff, W.M. Burke, and C.J. Cohen Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior Obstet Gynecol 112 2008 64 70
3. N.R. Abu-Rustum, Q. Zhou, J.D. Gomez, K.M. Alektiar, M.L. Hensley, and R.A. Soslow A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care Gynecol Oncol 116 2010 399 403
4. R. Rouzier, M. Preti, B. Haddad, M. Martin, L. Micheletti, and B.J. Paniel Development and validation of a nomogram for predicting outcome of patients with vulvar cancer Obstet Gynecol 107 2006 672 677
5. F.E. Harrell Jr. , R.M. Califf, D.B. Pryor, K.L. Lee, and R.A. Rosati Evaluating the yield of medical tests JAMA 247 1982 2543 2546
6. F.E. Harrell Jr. , K.L. Lee, D.B. Matchar, and T.A. Reichert Regression models for prognostic prediction: advantages, problems, and suggested solutions Cancer Treat Rep 69 1985 1071 1077
7. T.G. McGinn, G.H. Guyatt, P.C. Wyer, C.D. Naylor, I.G. Stiell, and W.S. Richardson Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-based medicine working group JAMA 284 2000 79 84
8. C.M. Lee, A. Szabo, D.C. Shrieve, O.K. Macdonald, J.D. Tward, and T.B. Skidmore Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study Cancer 110 2007 2092 2100
9. D.S. Dizon Treatment options for advanced endometrial carcinoma Gynecol Oncol 117 2010 373 381
10. A.A. Renshaw, M.L. Young, and M.R. Jiroutek How many cases need to be reviewed to compare performance in surgical pathology? Am J Clin Pathol 119 2003 388 391
11. D.E. Henson, and J. Albores-Saavedra Checking up on the surveillance, epidemiology, and end results program J Natl Cancer Inst 96 2004 1050 1051
12. N.R. Abu-Rustum, A. Iasonos, Q. Zhou, E. Oke, R.A. Soslow, and K.M. Alektiar Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol 198 2008 457 e1-5; discussion 457 e5-6
13. J.M. Cragun, L.J. Havrilesky, B. Calingaert, I. Synan, A.A. Secord, and J.T. Soper Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer J Clin Oncol 23 2005 3668 3675
14. M. Koskas, and R. Rouzier Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer Obstet Gynecol 117 2011 1225 1226
15. N.R. Abu-Rustum, Q. Zhou, A. Iasonos, K.M. Alektiar, M.M. Leitao Jr. , and D.S. Chi The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer 21 2011 511 516
16. C.P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
17. S.N. Lewin, T.J. Herzog, N.I. Barrena Medel, I. Deutsch, W.M. Burke, and X. Sun Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer Obstet Gynecol 116 2010 1141 1149
18. S. Bansal, A.M. Buck, T.J. Herzog, I. Deutsch, W.M. Burke, and J.D. Wright Stage IIIA endometrial carcinoma: outcome and predictors of survival Obstet Gynecol 114 2009 100 105
19. L.J. Havrilesky, A.A. Secord, D.M. O'Malley, G. Broadwater, V. Bae-Jump, and D.E. Cohn Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer Gynecol Oncol 114 2009 279 283
20. A. Mariani, M.J. Webb, G.L. Keeney, G. Aletti, and K.C. Podratz Assessment of prognostic factors in stage IIIA endometrial cancer Gynecol Oncol 86 2002 38 44